| ALD | Alcoholic liver disease |
| APRI | Aspartate-to-platelet ratio index |
| ATII | Angiotensin-II |
| CLD | Chronic liver disease |
| CSPH | Clinically significant portal hypertension |
| FIB-4 | Fibrosis-4 index |
| ELF | Enhanced liver fibrosis score |
| ET | Endothelin |
| FHVP | Free hepatic venous pressure |
| HCC | Hepatocellular carcinoma |
| HRS | Hepatorenal syndrome |
| HSC | Hepatic stellate cells |
| HVPG | Hepatic venous pressure gradient |
| HVR | Hepatic vascular resistance |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MELD | Model of End-Stage Liver Disease |
| MRE | Magnetic resonance Elastography |
| MRI | Magnetic Resonance Imaging |
| PH | Portal hypertension |
| SEC | Sinusoidal endothelial cell |
| TE | Transient elastography |
| TIMP-1 | Tissue inhibitor of metalloproteinase-1 |
| TIPS | Transjugular intrahepatic portosystemic shunt |
| WHVP | Wedged hepatic venous pressure |